Cwm LLC Has $4.88 Million Stock Position in Globe Life Inc. $GL

Cwm LLC lifted its position in Globe Life Inc. (NYSE:GL) by 72.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,225 shares of the company’s stock after buying an additional 16,530 shares during the quarter. Cwm LLC’s holdings in Globe Life were worth $4,875,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of GL. Principal Financial Group Inc. raised its stake in Globe Life by 4.1% during the 1st quarter. Principal Financial Group Inc. now owns 101,679 shares of the company’s stock valued at $13,393,000 after purchasing an additional 3,960 shares during the last quarter. DAVENPORT & Co LLC acquired a new position in Globe Life during the 1st quarter valued at $493,000. Atlas Capital Advisors Inc. acquired a new position in Globe Life during the 1st quarter valued at $893,000. Sequoia Financial Advisors LLC raised its stake in Globe Life by 693.4% during the 1st quarter. Sequoia Financial Advisors LLC now owns 24,184 shares of the company’s stock valued at $3,185,000 after purchasing an additional 21,136 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Globe Life by 8.0% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 9,711 shares of the company’s stock valued at $1,260,000 after purchasing an additional 723 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on GL. JPMorgan Chase & Co. upped their target price on shares of Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Cfra Research upgraded shares of Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. Wells Fargo & Company upped their target price on shares of Globe Life from $150.00 to $172.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a research note on Wednesday, October 8th. Finally, BMO Capital Markets reissued a “market perform” rating and issued a $149.00 price target (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $152.11.

Globe Life Trading Down 1.2%

Shares of Globe Life stock opened at $138.14 on Thursday. The firm has a market capitalization of $11.19 billion, a PE ratio of 11.04 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. The company’s fifty day moving average price is $140.11 and its two-hundred day moving average price is $128.95. Globe Life Inc. has a 52-week low of $100.27 and a 52-week high of $147.83.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.25 by $0.02. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a dividend of $0.27 per share. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is 8.63%.

Insider Activity

In related news, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the sale, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This trade represents a 27.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO James Matthew Darden sold 33,270 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the sale, the chief executive officer owned 49,842 shares of the company’s stock, valued at $6,758,076.78. This trade represents a 40.03% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 84,722 shares of company stock worth $11,733,793. Company insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.